ISPOR MEDICATION ADHERENCE AND PERSISTENCE SPECIAL INTEREST GROUP

Author(s)

Speakers: Mia Malmenas, Msc, MBA, Director, ICON plc, Stockholm, Sweden Bryan Bennett, PhD, Director, Bristol-Myers Squibb, Uxbridge, BKM, UK

Presentation Documents

Attendees interested in the management of patients with multiple chronic conditions, the clinical and economical challenges associated with poly-pharmacotherapy, and medication adherence are welcome to attend this open discussion. Grab your lunch and join us for a brief presentation on the recently released systematic review on the methods for measuring multiple medication adherence and a proposed follow up study. Discussion on the topics related to patients with multiple chronic conditions, such as how to evaluate adherence enhancing interventions and their influence on outcomes (e.g., quality of life, clinical outcomes, patient satisfaction, resource utilization, etc.), given the limited evidence on how to assess the effects of these interventions along multiple criteria will be presented. Attendees will have the opportunity to discuss ideas for future projects for the special interest group to develop and opportunities for member engagement. All attendees are welcome.

Conference/Value in Health Info

2019-05, ISPOR 2019, New Orleans, LA, USA
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×